Toll-like receptor 4 deficiency increases resistance in sepsis-induced immune dysfunction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Toll-like receptor 4 deficiency increases resistance in sepsis-induced immune dysfunction

Published:2018-01 Issue: Volume:54 Page:169-176
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Cao Chao,Chai Yanfen,Shou Songtao,Wang Jun,Huang Ying,Ma Tao

Funder

National Nature Science Foundation of China

Tianjin Research Program of Application Foundation and Advanced Technology of China

Techpool Fund of China

Theory E Emergency Medical Research Funds of China

TMUGH funding of China

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference32 articles.

1. Time to treatment and mortality during mandated emergency care for sepsis;Seymour;N. Engl. J. Med.,2017

2. The septic shock 3.0 definition and trials: a vasopressin and septic shock trial experience;Russell;Crit. Care Med.,2017

3. The surviving sepsis campaign's revised sepsis bundles;Barochia;Curr. Infect. Dis. Rep.,2013

4. Dissecting negative regulation of Toll-like receptor signaling;Kondo;Trends Immunol.,2012

5. The effects of TLR activation on T-cell development and differentiation;Jin;Clin. Dev. Immunol.,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toll-like receptor 4 (TLR4) deficiency impedes Toxoplasma gondii excreted-secreted antigens (ESA)-induced abortion;Placenta;2024-09

2. Advances and Challenges in Sepsis Management: Modern Tools and Future Directions;Cells;2024-03-02

3. Regulatory effects of mangiferin on LPS‐induced inflammatory responses and intestinal flora imbalance during sepsis;Food Science & Nutrition;2023-12-27

4. YBX-1 alleviates sepsis-stimulated lung epithelial cell injury;Allergologia et Immunopathologia;2023-03-01

5. Network pharmacology- and molecular simulation-based exploration of therapeutic targets and mechanisms of heparin for the treatment of sepsis/COVID-19;Journal of Biomolecular Structure and Dynamics;2023-01-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3